Remission Induction

Explore academic connections and research related to this keyword

272
Views
25
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
Feagan BG;Schreiber S;Wolf DC;Axler JL;Kaviya A;James A;Curtis RI;Geransar P;Stallmach A;Ehehalt R;B...
2019 inflammatory bowel diseases 398 views
2
[Discontinuation of immunosuppressive and immunomodulatory drugs in connective tissue diseases]
Targońska-Stępniak B;;
2015 Wiadomosci lekarskie (Warsaw, Poland : 1960) 328 views
3
Certolizumab pegol for induction of remission in Crohn's disease
Yamazaki H;So R;Matsuoka K;Kobayashi T;Shinzaki S;Matsuura M;Okabayashi S;Kataoka Y;Tsujimoto Y;Furu...
2019 The Cochrane database of systematic reviews 300 views
4
What happens after complete withdrawal of therapy in patients with lupus nephritis
Moroni G;Longhi S;Giglio E;Messa P;Ponticelli C;;
1970 Clinical and experimental rheumatology 382 views
5
Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society
Imashuku S;Hibi S;Ohara T;Iwai A;Sako M;Kato M;Arakawa H;Sotomatsu M;Kataoka S;Asami K;Hasegawa D;Ko...
1999 Blood 417 views
6
Remission and withdrawal of therapy in lupus nephritis
Moroni G;Raffiotta F;Ponticelli C;;
2016 journal of nephrology 255 views
7
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis
Mosli MH;MacDonald JK;Bickston SJ;Behm BW;Tsoulis DJ;Cheng J;Khanna R;Feagan BG;;
2015 inflammatory bowel diseases 313 views
8
Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
Imashuku S;Teramura T;Tauchi H;Ishida Y;Otoh Y;Sawada M;Tanaka H;Watanabe A;Tabata Y;Morimoto A;Hibi...
2004 Haematologica 452 views
9
[Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission]
Mallick A;Fautrel B;Sagez F;Sordet C;Javier RM;Petit H;Chatelus E;Rahal N;Gottenberg JE;Sibilia J;;
2017 la revue de medecine interne 292 views
10
Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial
Jha MK;Minhajuddin A;Greer TL;Carmody T;Rush AJ;Trivedi MH;;
2016 the american journal of psychiatry 360 views
11
Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
Yoshida M;Tsubaki K;Kobayashi T;Tanimoto M;Kuriyama K;Murakami H;Minami S;Hiraoka A;Takahashi I;Naoe...
1999 international journal of hematology 374 views
12
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
Harbord M;Eliakim R;Bettenworth D;Karmiris K;Katsanos K;Kopylov U;Kucharzik T;Molnár T;Raine T;Sebas...
2017 journal of crohn's & colitis 580 views
13
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group
Kogawa K;Sato H;Asano T;Ohga S;Kudo K;Morimoto A;Ohta S;Wakiguchi H;Kanegane H;Oda M;Ishii E;;
2014 pediatric blood & cancer 418 views
14
Early normalization of Quality of Life predicts later remission in depression: Findings from the CO-MED trial
Jha MK;Greer TL;Grannemann BD;Carmody T;Rush AJ;Trivedi MH;;
2016 Journal of affective disorders 277 views
15
Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life
Hommes D;Colombel JF;Emery P;Greco M;Sandborn WJ;;
2012 journal of crohn's & colitis 271 views
16
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)
Rowe JM;Andersen JW;Mazza JJ;Bennett JM;Paietta E;Hayes FA;Oette D;Cassileth PA;Stadtmauer EA;Wierni...
1995 Blood 330 views
17
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
Pineton de Chambrun G;Blanc P;Peyrin-Biroulet L;;
2016 expert review of gastroenterology & hepatology 276 views
18
Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice
Römkens TE;Gijsbers K;Kievit W;Hoentjen F;Drenth JP;;
2016 Journal of gastrointestinal and liver diseases : J... 235 views
19
Adalimumab induces deep remission in patients with Crohn's disease
Colombel JF;Rutgeerts PJ;Sandborn WJ;Yang M;Camez A;Pollack PF;Thakkar RB;Robinson AM;Chen N;Mulani...
2014 clinical gastroenterology and hepatology : the off... 229 views
20
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease
Kiss LS;Szamosi T;Molnar T;Miheller P;Lakatos L;Vincze A;Palatka K;Barta Z;Gasztonyi B;Salamon A;Hor...
2011 alimentary pharmacology & therapeutics 290 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis research support non-u.s. gov't adult female male Antibodies Monoclonal follow-up studies pmid:30365009 PMC6499937